| Delivery of a liposomal c-raf-1 antisense oligonucleotide by weekly bolus dosing in patients with advanced solid tumors: a phase I study CM Rudin, JL Marshall, CH Huang, HL Kindler, C Zhang, D Kumar, ... Clinical cancer research 10 (21), 7244-7251, 2004 | 116 | 2004 |
| Phase I study of liposome-encapsulated c-raf antisense oligodeoxyribonucleotide infusion in combination with radiation therapy in patients with advanced malignancies. A Dritschilo, CH Huang, CM Rudin, J Marshall, B Collins, JL Dul, C Zhang, ... Clinical cancer research: an official journal of the American Association …, 2006 | 105 | 2006 |
| Topotecan in the treatment of relapsed small cell lung cancer patients with poor performance status J Treat, CH Huang, SR Lane, J Levin The Oncologist 9 (2), 173-181, 2004 | 56 | 2004 |
| New advances in lung cancer chemotherapy: topotecan and the role of topoisomerase I inhibitors CH Huang, J Treat Oncology 61 (Suppl. 1), 14-24, 2001 | 36 | 2001 |
| Randomized phase II trial of cisplatin, etoposide, and radiation followed by gemcitabine alone or by combined gemcitabine and docetaxel in stage III A/B unresectable non-small … B Movsas, CJ Langer, HJ Ross, L Wang, RM Jotte, S Feigenberg, F Xu, ... Journal of Thoracic Oncology 5 (5), 673-679, 2010 | 22 | 2010 |
| Openfermion: The electronic structure package for quantum computers (2017) JR McClean, KJ Sung, ID Kivlichan, Y Cao, C Dai, ES Fried, C Gidney, ... arXiv preprint arXiv:1710.07629 1710, 2022 | 13 | 2022 |
| Phase I trial in advanced malignancies with liposome encapsulated paclitaxel (LEP) JA Treat, C Huang, N Damjanov, S Walker, P Drobins, P Gokhale, ... Lung Cancer 1 (29), 64, 2000 | 9 | 2000 |
| Infusion of liposome-encapsulated c-raf antisense oligodeoxynucleotide (LErafAON) during radiation therapy in patients with advanced malignancies: a phase I study A Dritschilo, CH Huang, C Fleming, CM Rudin, J Marshall, B Collins, ... Proc Am Soc Clin Oncol 22, 224, 2003 | 6 | 2003 |
| Liposome-encapsulated c-raf antisense oligodeoxynucleotide (LErafAON) in patients with advanced solid tumors: Phase I study of daily infusion during radiation therapy A Dritschilo, C Huang, L Strauss, C Fleming, A Rahman, C Rudin, ... Proc Am Soc Clin Oncol 21, 28a, 2002 | 5 | 2002 |
| ZD0473 phase II monotherapy trial in second-line non-small cell lung cancer J Treat, C Huang, N Damanjov, M Jahanzeb, M Edelman, M Koehler European Journal of Cancer 37, S59-S60, 2001 | 4 | 2001 |
| P-579 Topotecan in the treatment of relapsed small cell lung cancer patients with poor performance status J Treat, CH Huang Lung Cancer, S237, 2003 | 3 | 2003 |
| Intermittent bolus dosing (weekly infusions) with a liposome-encapsulated c-raf antisense oligonucleotide (LErafAON) in patients with advanced solid tumors: A phase I study CH Huang, CM Rudin, J Marshall Proc Am Soc Clin Oncol 22, 199, 2003 | 3 | 2003 |
| Delivery of a c-raf antisense oligodeoxynucleotide (LErafAON) by intermittent bolus dosing (weekly infusions) in patients with advanced solid tumors: a phase I study CM Rudin, J Marshall, CH Huang, L Strauss, C Fleming, C Zhang, ... EUROPEAN JOURNAL OF CANCER 38, S142-S142, 2002 | 3 | 2002 |
| Phase II trial evaluating combination, weekly gemcitabine and docetaxel in progressive, chemotherapy-exposed NSCLC: Preliminary results of OPN 003 CH Huang, CJ Langer, MM Millenson, E Sherman, J Seldomridge, ... Journal of Clinical Oncology 23 (16_suppl), 7295-7295, 2005 | 1 | 2005 |
| P-521 Phase II trial evaluating combination, weekly gemcitabineand docetaxel in progressive, chemotherapy-exposed NSCLC: Preliminary results of OPN 003 C Langer, C Huang, M Millenson, E Sherman, J Seldomridge, J Schol, ... Lung Cancer, S254, 2005 | | 2005 |
